AzTrials
AzTrials

TraumaEALNCT05579717

Examining the Effectiveness of EAL

A study testing Equine Assisted Learning in people with Trauma, run by McMaster University at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This quasi-experiment will evaluate the effectiveness of Equine Assisted Learning for reducing symptoms associated with trauma exposure among public safety personnel (e.g., fire fighters, police, paramedics, etc.). Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Trauma
What is being tested?
Equine Assisted Learning
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteCanada
Study dates
1 Mar 2022to 31 Aug 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • English-speaking adults;
  • Currently or previously employed as public safety personnel (e.g., police officer, fire fighter, paramedic, healthcare worker, emergency dispatcher, correctional officer);
  • Reside in Saskatchewan;
  • Meet diagnostic criteria for having experienced a Criterion A traumatic event;
  • Able to provide written informed consent;
  • Have access to a smart phone, tablet, or computer with a working microphone and camera; and
  • Have access to consistent and reliable internet.

Who cannot join

  • Meet/met current/past diagnostic criteria for several psychiatric, neurodevelopmental, and neurological conditions;
  • History of severe head trauma with loss of consciousness or history of traumatic brain injury;
  • Have previously completed at least half of the EAL curriculum at Cartier Farms.

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Cartier Farms

    Prince Albert, Saskatchewan, S6V5R2

Other trials in Canada

About this study

Official title: Examining the Effectiveness of Equine Assisted Learning for Trauma-exposed Public Safety Personnel

This quasi-experiment will evaluate the effectiveness of Equine Assisted Learning for reducing symptoms associated with trauma exposure among public safety personnel (e.g., fire fighters, police, paramedics, etc.).

Read the detailed description

The purpose of the proposed project is to investigate the effectiveness of Equine Assisted Learning (EAL) for reducing symptoms associated with trauma exposure among public safety personnel. EAL is an intervention in which mental health clinicians and equine specialists work together with clients to address a learning goal via unmounted interaction with a horse. Recent literature indicates that EAL shows promise in addressing a range of mental health diagnoses among a variety of populations, including military and Royal Canadian Mounted Police veterans with PTSD. The EAL intervention will be delivered at Cartier Farms in Spruce Home, Saskatchewan. Research components of this study will be conducted virtually via Zoom.

The investigators will employ a quasi-experimental design with pre-post and follow-up testing. Participants will be assigned one of two groups based on the time that they complete their initial baseline interview: (1) the intervention group will receive the EAL intervention for 8 weeks, while (2) the waitlist control condition will not receive this treatment for the same amount of time. Data on trauma exposure symptom severity will be collected from all participants prior to the start of the the study (baseline), again 8 weeks later (post), and then a final time 3 months later (follow-up). The two conditions will then be compared to determine whether there are differences in trauma exposure symptom severity between groups. To obtain a sufficient sample size while also running appropriately sized interventions of 6-10 participants per session, the researchers will conduct 4-6 rounds of group assignment. All individuals in the waitlist control condition will be offered EAL following their completion of the study.

Conditions
Trauma
Being tested
Equine Assisted Learning
Keywords
EAL, PTSD, posttraumatic stress disorder, public safety personnel, first responder, Equine Assisted Learning, horse therapy, trauma
Medical subject headings
Wounds and Injuries, Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Equine Assisted LearningBehavioural

    Also called EAL

    EAL is an intervention in which mental health clinicians and equine specialists work together with clients to address a learning goal via unmounted interaction with a horse. It is 16 sessions in length, at a rate of two sessions per week.

Study groups in NCT05579717
Study groupRoleWhat they receive
Equine Assisted Learning groupExperimentalParticipants in this group will receive 16 sessions of Equine Assisted Learning (EAL), facilitated by a trained clinician at Cartier Farms.
Receives: Behavioral: Equine Assisted Learning
Waitlist control groupNo interventionParticipants in the waitlist control group will not receive EAL for the duration of the study.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PTSD symptomatology

    Changes in performance on the Clinician Administered PTSD Scale (structured interview) at pre, post, and follow-up.

    Measured: 20 weeks

  2. PTSD symptomatology

    Changes in performance on the PTSD Checklist for DSM-5 at pre, post, and follow-up. Scores can range between 0 and 80 with higher scores denoting higher PTSD symptomatology.

    Measured: 20 weeks

Secondary outcomes (18)
  1. Mental health symptomatology

    Changes in performance on the Mini International Neuropsychiatric Interview (structured interview) at pre, post, and follow-up.

    Measured: 20 weeks

  2. Depression, anxiety, and stress symptomatology

    Changes in performance on the Depression Anxiety Stress Scale at pre, post, and follow-up. Scores can range between 0 and 42 with higher scores denoting higher depression, anxiety, and/or stress symptomatology.

    Measured: 20 weeks

  3. Substance involvement

    Changes in performance on the World Health Organization's Alcohol, Smoking, and Substance Involvement Test at pre, post, and follow-up. Each question on the ASSIST has a checklist set of responses to choose from to measure substances used in the past, and each response from questions 2 to 7 has a numerical score. Higher scores indicate more significant substance involvement.

    Measured: 20 weeks

  4. Health complaints

    Changes in performance on the Physical Symptoms Questionnaire at pre, post, and follow-up. Scores can range between 0 and 33 with higher scores denoting more health complaints.

    Measured: 20 weeks

  5. Sleep quality

    Changes in performance on the Pittsburgh Sleep Quality Index at pre, post, and follow-up. Scores can range between 0 and 21 with higher scores denoting poorer sleep quality.

    Measured: 20 weeks

  6. Body awareness

    Changes in performance on the Multidimensional Assessment of Interoceptive Awareness - Version 2 at pre, post, and follow-up. Scores can range between 0 and 185 with higher scores denoting greater body awareness.

    Measured: 20 weeks

  7. Moral injury

    Changes in performance on the Moral Injury Assessment - Public Safety Personnel at pre, post, and follow-up. Scores can range between 17 and 102 with higher scores denoting higher moral injury.

    Measured: 20 weeks

  8. Dissociation

    Changes in performance on the Multiscale Dissociation Index at pre, post, and follow-up. Scores can range between 0 and 120 with higher scores denoting higher dissociative symptomatology.

    Measured: 20 weeks

  9. Emotion regulation

    Changes in performance on the Difficulties in Emotion Regulation Scale, at pre, post, and follow-up. Scores can range between 36 and 180 with higher scores denoting poorer emotion regulation.

    Measured: 20 weeks

  10. Exposure to childhood trauma

    Baseline description of trauma experienced in childhood based on the Childhood Trauma Questionnaire, which is a 28-item checklist where more endorsed traumatic experiences indicates more exposure to childhood trauma.

    Measured: Completed once at baseline

  11. Alcohol use disorder symptomatology

    Changes in performance on the Alcohol Use Disorder Identification Test at pre, post, and follow-up. Scores can range between 0 and 40 with higher scores denoting higher AUD symptomatology.

    Measured: 20 weeks

  12. Cannabis use disorder symptomatology

    Changes in performance on the Cannabis Use Disorder Identification Test at pre, post, and follow-up. Scores can range between 0 and 32 with higher scores denoting higher CUD symptomatology.

    Measured: 20 weeks

  13. Substance use disorder symptomatology

    Changes in performance on the Drug Use Disorder Identification Test at pre, post, and follow-up. Scores can range between 0 and 44 with higher scores denoting higher SUD symptomatology.

    Measured: 20 weeks

  14. Resilience

    Changes in performance on the Brief Resilience Scale at pre, post, and follow-up. Scores can range between 6 and 30 with higher scores denoting higher resilience.

    Measured: 20 weeks

  15. Self-compassion

    Changes in performance on the Self Compassion Scale at pre, post, and follow-up. Scores can range between 26 and 130 with higher scores denoting higher self-compassion.

    Measured: 20 weeks

  16. Health and disability

    Changes in performance on World Health Organization's Disability Assessment Schedule 12 at pre, post, and follow-up. Scores can range between 0 and 100 with higher scores denoting greater disability.

    Measured: 20 weeks

  17. Disability

    Changes in performance on the Sheehan Disability Scale at pre, post, and follow-up. Scores can range between 0 and 44 with higher scores denoting greater disability.

    Measured: 20 weeks

  18. Work functioning and productivity

    Changes in performance on Lam's Employment and Productivity Scale at pre, post, and follow-up. Scores can range between 0 and 28 with higher scores denoting more severe work impairment.

    Measured: 20 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Oct 2022
  2. Study start1 Mar 2022
  3. Primary completion31 Aug 2025
  4. Study completion31 Aug 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Crossover
Model description
Participants will be assigned to an intervention group or a waitlist control group based on the time they complete their initial baseline interview. Individuals in the waitlist control group will be offered the opportunity to participate in EAL once they have completed the study.
Masking
None (open label)
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05579717
Sponsor's protocol ID
14547
Acronym
EAL
Status last verified
Dec 2025
First submitted
28 Sep 2022
Last updated
9 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Equine Assisted Learning in people with Trauma, run by McMaster University at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PTSD symptomatology (time frame: 20 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in